Cambridge Advisors Inc. Amgen Inc Transaction History

Cambridge Advisors Inc.

$416 Million
Q1 2024

A detailed history of Cambridge Advisors Inc. transactions in Amgen Inc stock. As of the latest transaction made, Cambridge Advisors Inc. holds 25,218 shares of AMGN stock, worth $7.88 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

25,218

Previous 25,290 0.28%

Holding current value

$7.88 Million

Previous $7.28 Million 1.58%

% of portfolio

1.72%

Previous 1.86%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $19,358 - $23,368	-72 Reduced 0.28%	25,218 $7.17 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $9,972 - $11,249	-39 Reduced 0.15%	25,290 $7.28 Million
Q3 2023 Oct 18, 2023	BUY	$218.65 - $271.46 $6,778 - $8,415	31 Added 0.12%	25,329 $6.81 Million
Q2 2023 Jul 13, 2023	SELL	$214.27 - $253.37 $31,497 - $37,245	-147 Reduced 0.58%	25,298 $5.62 Million
Q1 2023 Apr 13, 2023	BUY	$225.79 - $275.2 $42,222 - $51,462	187 Added 0.74%	25,445 $6.15 Million

Q4 2022 Jan 23, 2023	BUY	$229.03 - $291.01 $12,825 - $16,296	56 Added 0.22%	25,258 $0
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $74,296 - $83,792	-331 Reduced 1.3%	25,202 $5.68 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $12,458 - $13,863	-54 Reduced 0.21%	25,533 $6.21 Million
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $22,146 - $24,499	101 Added 0.4%	25,587 $6.19 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $6,960 - $7,966	35 Added 0.14%	25,486 $5.73 Million
Q3 2021 Oct 19, 2021	BUY	$212.27 - $248.7 $25,684 - $30,092	121 Added 0.48%	25,451 $5.41 Million
Q2 2021 Jul 21, 2021	SELL	$233.58 - $259.14 $7,474 - $8,292	-32 Reduced 0.13%	25,330 $6.17 Million
Q1 2021 Apr 22, 2021	BUY	$221.91 - $258.6 $2,662 - $3,103	12 Added 0.05%	25,362 $6.31 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $22,070 - $26,282	102 Added 0.4%	25,350 $5.83 Million
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $16,660 - $18,527	71 Added 0.28%	25,248 $6.42 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $19,978 - $24,516	101 Added 0.4%	25,177 $5.94 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $24,602 - $32,629	-135 Reduced 0.54%	25,076 $5.08 Million
Q4 2019 Jan 28, 2020	BUY	$189.21 - $243.2 $4.77 Million - $6.13 Million	25,211 New	25,211 $6.08 Million
Q3 2019 Oct 25, 2019	SELL	$174.11 - $208.62 $4.45 Million - $5.33 Million	-25,556 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $69,847 - $81,876	-419 Reduced 1.61%	25,556 $4.71 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $162,783 - $183,492	-900 Reduced 3.35%	25,975 $4.94 Million
Q4 2018 Jan 29, 2019	BUY	$178.4 - $208.25 $17,126 - $19,992	96 Added 0.36%	26,875 $5.23 Million
Q3 2018 Oct 24, 2018	BUY	$185.29 - $208.89 $17,046 - $19,217	92 Added 0.34%	26,779 $5.55 Million
Q2 2018 Jul 30, 2018	SELL	$166.05 - $186.51 $47,490 - $53,341	-286 Reduced 1.06%	26,687 $4.93 Million
Q1 2018 Apr 18, 2018	BUY	$169.43 - $198.0 $129,275 - $151,074	763 Added 2.91%	26,973 $4.6 Million
Q4 2017 Jan 26, 2018	SELL	$168.79 - $188.59 $125,242 - $139,933	-742 Reduced 2.75%	26,210 $4.56 Million
Q3 2017 Oct 27, 2017	BUY	$167.29 - $191.0 $4.51 Million - $5.15 Million	26,952	26,952 $5.03 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Advisors Inc. with notifications on news.

Account

Cambridge Advisors Inc. Amgen Inc Transaction History